Our state-of-the-art in-vitro facilities are equipped to perform a wide range of cellular assays, allowing us to investigate the cellular and molecular mechanisms underlying various types of cancer. With cutting-edge technology such as flow cytometry, high-throughput screening, and real-time PCR, we can rapidly assess the efficacy of novel therapeutic agents and understand their impact on cellular functions.